Article Information
History
- October 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Elizabeth M. Garry, PhD, MPH1,
- Andrew R. Weckstein, BA1,
- Kenneth Quinto, MD, MPH2,
- Tamar Lasky, PhD, FISPE3,
- Aloka Chakravarty, PhD, MStat3,
- Sandy Leonard, MPH4,
- Sarah E. Vititoe, MPH1,
- Imaani J. Easthausen, MS1,
- Jeremy A. Rassen, ScD, FISPE1 and
- Nicolle M. Gatto, PhD, MPH, FISPE1,*
- 1Aetion, Inc., New York, NY, USA
- 2Office of Medical Policy, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA
- 3Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD, USA
- 4Partnerships and RWD, HealthVerity, Philadelphia, PA, USA
- ↵*Corresponding author; email: nicolle.gatto{at}aetion.com
Posted October 05, 2021.
Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity
